Showing results (51-60 of 92) with videos related to
Sort By:
Pageof 10
Biorxiv : the Preprint Server for Biology|August 8, 2025
The Plasma Membrane may Serve as a Drug Depot to Drive the Extreme Potency of FentanylJoseph Clayton, George J Farmer, Jackie Glenn, et al.JACS Au|March 27, 2026
Membrane Permeability Drives the Extreme Potency of FentanylJoseph Clayton, George J Farmer, Jacqueline Glenn, et al.Chemical Communications (Cambridge, England)|May 24, 2024
Enantioselective de novo synthesis of 14-hydroxy-6-oxomorphinansJonathan C Moore, Louis Modell, Jacqueline R Glenn, et al.Journal of Medicinal Chemistry|January 26, 2010
Structure-based discovery of novel chemotypes for adenosine A(2A) receptor antagonistsVsevolod Katritch, Veli-Pekka Jaakola, J Robert Lane, et al.Journal of Medicinal Chemistry|October 4, 2019
Structure-Kinetic Profiling of Haloperidol Analogues at the Human Dopamine D2 ReceptorTim J Fyfe, Barrie Kellam, David A Sykes, et al.Plos Computational Biology|January 17, 2018
The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptorsRavi Kumar Verma, Ara M Abramyan, Mayako Michino, et al.Journal of Medicinal Chemistry|December 2, 2015
4-Phenylpyridin-2-one Derivatives: A Novel Class of Positive Allosteric Modulator of the M1 Muscarinic Acetylcholine ReceptorShailesh N Mistry, Manuela Jörg, Herman Lim, et al.Plos One|September 11, 2024
The chemokine receptor CCR8 is not a high-affinity receptor for the human chemokine CCL18Khansa Hussain, Herman D Lim, Shankar Raj Devkota, et al.The Journal of Biological Chemistry|January 21, 2014
Molecular determinants of allosteric modulation at the M1 muscarinic acetylcholine receptorAlaa Abdul-Ridha, Laura López, Peter Keov, et al.Journal of Medicinal Chemistry|April 24, 2018
A Thieno[2,3- d]pyrimidine Scaffold Is a Novel Negative Allosteric Modulator of the Dopamine D2 ReceptorTim J Fyfe, Barbara Zarzycka, Herman D Lim, et al.Pageof 10